U.S. rejection of new mRNA flu vaccine sends chills, epidemiologist says [ER9tymgizaO]
The U.S. Food and Drug Administration announced recently that it will not review Moderna’s mRNA flu vaccine, despite late-stage trials showing it was safe and effective. The rejection has many in and outside the industry concerned about the Trump administration’s approach to vaccine development and recommendations. Amna Nawaz discussed more with Michael Osterholm. Watch PBS News for daily, breaking and live news, plus special coverage. We are home to PBS News Hour, ranked the most credible and objective TV news show. Sign up for Here's The Deal with Lisa Desjardins: Subscribe for exclusive content in our newsletters: PBS News podcasts: Stream your PBS favorites with the PBS app: Find more from PBS News at Subscribe to our YouTube channel: Follow us: TikTok: X: Instagram: Facebook: